OR WAIT null SECS
October 20, 2025
Take this quiz to test your comprehension of one of our recent feature articles.
October 17, 2025
As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product integrity, and regulatory compliance through automation and sustainable materials.
Biopharma R&D strategy pivots: M&A favors late-stage assets, obesity deals surge, AI accelerates manufacturing, and policy drives strategic US facility investment.
October 16, 2025
Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.
Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and development into the next decade, according to a BCC Research report.
October 15, 2025
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development or orphan drugs.
Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant upfronts flowing toward innovation in China were key in Q3 2025.
The company will also highlight its sustainability strategies and quality solutions at the event.
October 14, 2025
The European Union aims to become the most attractive place for life science by 2030.